Abstract
About 25-30% of patients with immune thrombocytopenic purpura (ITP) are refractory to corticosteroids, splenectomy and other treatments. It has been suggested that interferon-alpha 2b (IFN-alpha 2b) may be useful in the treatment of chronic refractory ITP patients. We treated 9 chronic refractory ITP patients with IFN-alpha 2b: the results were poor.
MeSH terms
-
Adult
-
Aged
-
Autoimmune Diseases / therapy*
-
Female
-
Humans
-
Immunologic Factors / therapeutic use*
-
Immunosuppressive Agents / therapeutic use
-
Interferon alpha-2
-
Interferon-alpha / therapeutic use*
-
Male
-
Middle Aged
-
Purpura, Thrombocytopenic, Idiopathic / therapy*
-
Recombinant Proteins
-
Salvage Therapy
-
Treatment Failure
Substances
-
Immunologic Factors
-
Immunosuppressive Agents
-
Interferon alpha-2
-
Interferon-alpha
-
Recombinant Proteins